Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Fresenius Medical Care AG & Co. KGaA's quarterly P/E stands at 25.6x, up 7.1% year-over-year. EV/EBITDA has compressed 21.2% YoY to 6.6x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 12.27 | 25.64 | 10.45 | 14.01 | 18.31 | 23.94 | 94.33 | 28.03 | 29.83 | 80.33 | 23.67 | 56.68 | 37.39 |
| — | +7.1% | -88.9% | -50.0% | -38.6% | -70.2% | +298.5% | -50.6% | -20.2% | +51.1% | -30.5% | +223.0% | -22.0% | |
| P/S Ratio | 0.58 | 0.67 | 0.67 | 0.79 | 0.87 | 0.75 | 1.31 | 1.31 | 1.18 | 1.20 | 0.92 | 0.96 | 1.09 |
| — | -10.1% | -48.6% | -40.0% | -25.6% | -37.5% | +42.2% | +36.8% | +7.7% | +20.4% | -4.2% | +18.9% | -29.0% | |
| P/B Ratio | 0.84 | 0.87 | 0.95 | 1.11 | 1.17 | 0.94 | 1.69 | 1.69 | 1.48 | 1.50 | 1.24 | 1.23 | 1.41 |
| — | -7.2% | -43.4% | -34.5% | -20.7% | -37.0% | +36.3% | +37.6% | +4.6% | +21.7% | -0.3% | +24.8% | -25.5% | |
| P/FCF | 6.69 | 84.31 | 6.04 | 7.01 | 6.75 | 214.08 | 11.24 | 7.63 | 19.79 | — | 9.77 | 7.61 | 6.18 |
| — | -60.6% | -46.3% | -8.2% | -65.9% | — | +15.0% | +0.3% | +220.2% | — | -24.4% | -8.1% | -51.0% | |
| EV / EBITDA | 6.28 | 6.62 | 6.03 | 7.06 | 8.14 | 8.40 | 32.38 | 10.51 | 10.19 | 11.05 | 8.49 | 9.76 | 10.35 |
| — | -21.2% | -81.4% | -32.8% | -20.1% | -24.0% | +281.2% | +7.7% | -1.6% | +0.5% | -7.5% | +30.5% | -24.6% | |
| EV / EBIT | 11.25 | 18.46 | 11.21 | 12.91 | 14.58 | 17.60 | 32.38 | 18.15 | 18.68 | 32.04 | 15.95 | 21.76 | 21.50 |
| — | +4.9% | -65.4% | -28.9% | -21.9% | -45.1% | +103.0% | -16.6% | -13.1% | +13.8% | -22.7% | +45.7% | -27.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Fresenius Medical Care AG & Co. KGaA's operating margin was 8.1% in Q1 2026, down 3.6 pp QoQ and up 1.4 pp YoY. The trailing four-quarter average of 9.6% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin expanded 5.4% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 25.6% | 25.6% | 27.4% | 25.4% | 25.3% | 24.3% | 25.0% | 24.1% | 24.5% | 24.8% | 27.1% | 24.9% | 24.8% |
| — | +5.4% | +9.6% | +5.6% | +3.6% | -2.4% | -7.7% | -3.3% | -1.4% | +1.7% | +0.3% | +2.0% | -5.3% | |
| Operating Margin | 9.3% | 8.1% | 11.7% | 9.8% | 8.9% | 6.8% | 5.1% | 9.7% | 8.9% | 5.2% | 8.6% | 6.6% | 7.4% |
| — | +19.9% | +129.7% | +0.3% | -0.5% | +30.4% | -40.5% | +48.2% | +20.5% | -6.2% | +21.7% | -29.1% | +3.4% | |
| Net Margin | 5.0% | 2.6% | 6.4% | 5.6% | 4.7% | 3.1% | 1.3% | 4.5% | 3.9% | 1.5% | 3.8% | 1.7% | 2.9% |
| — | -16.1% | +390.1% | +25.7% | +19.8% | +106.3% | -65.1% | +162.9% | +35.2% | -17.8% | +35.6% | -62.3% | -6.2% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 6.5% | 0.8% | 2.3% | 1.9% | 1.5% | 1.0% | 0.4% | 1.4% | 1.2% | 0.5% | 1.2% | 0.6% | 0.9% |
| — | -12.9% | +429.8% | +37.0% | +22.4% | +104.2% | -64.7% | +156.8% | +32.8% | -15.5% | +44.0% | -61.3% | -5.4% | |
| ROA | 3.0% | 0.4% | 1.1% | 0.9% | 0.7% | 0.5% | 0.2% | 0.6% | 0.5% | 0.2% | 0.5% | 0.2% | 0.4% |
| — | -15.8% | +421.8% | +37.8% | +28.4% | +119.4% | -62.5% | +169.5% | +37.9% | -13.9% | +44.3% | -61.5% | -4.4% | |
| ROIC | 5.6% | 1.2% | 1.9% | 1.5% | 1.3% | 1.0% | 0.8% | 1.4% | 1.2% | 0.7% | 1.2% | 0.9% | 1.0% |
| — | +21.4% | +146.8% | +11.2% | +6.2% | +36.5% | -36.8% | +51.3% | +23.6% | -0.0% | +31.8% | -26.2% | +6.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Fresenius Medical Care AG & Co. KGaA's Debt/EBITDA ratio is 13.2x, up from 11.4x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 17.5% YoY to 1.20x, tightening the short-term liquidity position. Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.76 | 0.78 | 0.76 | 0.75 | 0.77 | 0.70 | 0.70 | 0.76 | 0.78 | 0.80 | 0.81 | 0.84 | 0.88 |
| — | +11.0% | +8.3% | -0.8% | -0.8% | -12.2% | -14.3% | -9.7% | -11.4% | -8.5% | -4.8% | +2.0% | -1.0% | |
| Debt / EBITDA | 3.30 | 13.15 | 11.41 | 12.02 | 13.77 | 14.94 | 39.17 | 13.54 | 14.51 | 15.90 | 14.15 | 16.68 | 16.52 |
| — | -11.9% | -70.9% | -11.2% | -5.1% | -6.0% | +176.8% | -18.8% | -12.2% | -16.3% | -9.3% | +17.8% | -7.8% | |
| Current Ratio | 1.26 | 1.20 | 1.26 | 1.36 | 1.44 | 1.46 | 1.40 | 1.37 | 1.46 | 1.50 | 1.42 | 1.37 | 1.26 |
| — | -17.5% | -9.6% | -1.1% | -1.8% | -2.4% | -1.7% | +0.4% | +16.2% | +13.5% | +12.2% | +2.2% | +6.9% | |
| Quick Ratio | 0.92 | 0.86 | 0.92 | 1.00 | 1.08 | 1.08 | 1.03 | 1.02 | 1.09 | 1.14 | 1.07 | 1.02 | 0.91 |
| — | -20.1% | -10.9% | -2.1% | -0.4% | -5.2% | -3.1% | -0.2% | +20.0% | +18.6% | +16.8% | +6.2% | +7.1% | |
| Interest Coverage | — | — | — | 6.44 | 4.63 | 3.62 | 2.78 | 4.85 | 4.30 | 2.52 | 4.08 | 3.06 | 3.63 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Deep dive into FMS consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FMS stock.
Fresenius Medical Care AG & Co. KGaA's current P/E is 12.3x. The average P/E over the last 4 quarters is 17.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Fresenius Medical Care AG & Co. KGaA's current operating margin is 9.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Fresenius Medical Care AG & Co. KGaA's business trajectory between earnings reports.